ascochlorin a

Ascochlorin A is a novel and potent hDHODH inhibitor ( K D = 3.29 μM) for treatment of triple-negative breast cancer.

Ascochlorin (Ilicicolin D), an isoprenoid antibiotic, primarily exerts its anti-tumor properties by inhibiting the STAT3 signaling pathway. It induces apoptosis and possesses anti-inflammatory activity[1][2][3].